Journal Mobile Options
Table of Contents
Vol. 25, No. 5, 2002
Issue release date: October 2002
Onkologie 2002;25:406–411
(DOI:10.1159/000067433)
Focus: Nicotine and Tobacco · Original Article

Preclinical Development of a Vaccine ‘Against Smoking’

Cerny E.H.a · Lévy R.a · Mauel J.b · Mpandi M.c · Mutter M.d · Henzelin-Nkubana C.d · Patiny L.d · Tuchscherer G.d · Cerny T.e
aChilka Ltd., Lausanne; bInstitut de Biochemie, ISREC, Epalinges; cSerolab SA, Remaufens; dInstitut of Molecular and Biological Chemistry, Swiss Federal Institute of Technology, Lausanne; eDepartment of Oncology/Haematology, Cantonal Hospital St. Gall, CH

Abstract

Background: Nicotine is the main culprit for dependence on tobacco-containing products, which in turn are a major etiologic factor for cardiovascular diseases and cancer. This publication describes a vaccine, which elicits antibodies against nicotine. The antibodies in the blood stream intercept the nicotine molecule on its way to its receptors and greatly diminish the nicotine influx to the brain shortly after smoking. Methods: The nicotine molecule is chemically linked to cholera toxin B as a carrier protein in order to induce antibodies. The potential to elicit antibodies after subcutaneous as well as intranasal immunization is evaluated. In order to simulate realistic conditions, nicotine pumps delivering the nicotine equivalent of 5 packages of cigarettes for 4 weeks are implanted into the mice 1 week prior to vaccination. The protective effect of the vaccine is measured 5 weeks after vaccination by comparing the influx of radiolabeled nicotine in the brains of vaccinated and non-vaccinated animals 5 min after challenge with the nicotine equivalent of 2 cigarettes. Results: The polyclonal antibodies induced by the vaccine show a mean avidity of 1.8 × 107 l/Mol. Subcutaneous immunization elicits high antibody levels of the IgG class, and significant IgA antibody levels in the saliva of vaccinated mice can be found after intranasal vaccination. The protective effect also in the animals with implanted nicotine pumps is significant: less than 10% of radiolabeled nicotine found in the brains of non-vaccinated animals can be found in the brains of vaccinated animals. Conclusions: These data provide credible evidence that a vaccine can break the vicious circle between smoking and instant gratification by intercepting the nicotine molecule. Astonishingly, there is no sign of exhaustion of specific antibodies even under extreme conditions, which makes it highly unlikely that a smoker can overcome the protective effect of the vaccine by smoking more. Finally, the high titers of specific antibodies after 1 year let us hope that booster vaccinations are probably only necessary in intervals of years.

 goto top of outline Publication Details

Onkologie (International Journal for Cancer Research and Treatment)
Offizielles Organ der Deutschen Gesellschaft für Hämatologie und Onkologie, der Österreichischen Gesellschaft für Hämatologie und Onkologie, der Österreichischen Krebsgesellschaft–Krebsliga unter Fortführung der ‘Österreichischen Zeitung für Onkologie’

Vol. 25, No. 5, Year 2002 (Cover Date: October 2002)

Journal Editor: W. Queisser, Mannheim, Germany, W. Scheithauer, Wien, Austria
ISSN: 0378–584X (print), 1423–0240 (Online)

For additional information: http://www.karger.com/journals/onk


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.